The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)
Scientific Indexing Services (USA)
CAS Source index (USA)
Web of Science Group (USA)

AN INTEGRATIVE REVIEW OF THE EVIDENCE ON THE EFFICACY OF THE ANTIHOMOTOXIC MEDICATION TRAUMEEL

DOI: https://doi.org/None
Issue: 
3
Year: 
2017

Robbert van Haselen International Institute for Integrated Medicine (INTMEDI), Kingston, United Kingdom

Introduction. Traumeel is a homeopathic medication used for the stand-alone or adjuvant bioregulatory therapy of inflammatory diseases of different organs and tissues, including locomotor diseases (tendovaginitis, bursitis, styloiditis, periarthritis, etc.) and various posttraumatic conditions (postoperative soft tissue swelling, muscle strain, and ligament sprain). Objective: to review the scientific literature on the efficiency of using Traumeel to treat inflammatory diseases of different organs and tissues. Material and methods. The available data on Traumeel were analyzed using an integrative approach, i.e. mixed methods. The analysis included both the determination of the level of evidence, by applying a hierarchical grading system, and the assessment of the data by non-hierarchical methods. Results. Twenty-two works, including 3 reviews, 6 clinical trials, 7 prospective cohort studies, and 7 publications on the results of basic research studies were analyzed. Conclusion. Studies on Traumeel comprise are a multifaceted and diverse evidence-base that increases every year. The integrative approach is of value in the context of individualized medical care.

Keywords: 
bioregulatory therapy
locomotor diseases
posttraumatic conditions
integrative approach
evidence base

References: 
  1. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. CEBM Web site. http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf. Accessed February 22, 2017.
  2. van Haselen R. Medical study formats: an overview. J Biomed Ther. 2010;4(2):26–7.
  3. Schneider C. Traumeel: an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries. Int J Gen Med. 2011;4:225-234. doi:10.2147/ijgm.s16709.
  4. Müller-Löbnitz C, Göthel D. Review of the clinical efficacy of the multicomponent combination medication Traumeel and its components. Altern Ther Health Med. 2011;17(suppl 2):S18–S31.
  5. Speed C, Wolfarth B. Challenges of pain masking in the management of soft tissue disorders: optimizing patient outcomes with a multi-targeted approach. Curr Med Res Opin. 2014;30(5): 953–9. doi:10.1185/03007995.2014.913412.
  6. Zell J, Connert WD, Mau J, Feuerstake G. Treatment of acute sprains of the ankle: a controlled double-blind trial to test the effectiveness of a homeopathic ointment. Biol Ther. 1989;7(1):1–6.
  7. Zell J, Connert WD, Mau J, Feuerstake G. Behandlung von Sprunggelenksdistorsionen: Doppelblindstudie zum Wirksamkeitsnachweis eines homöopathischen Salbenpräparats. Fortschr Med. 1988;106(5):96-100.
  8. Thiel W, Borho B. The treatment of recent traumatic blood effusions of the knee joint. Biol Ther. 1994;12(4):242–8.
  9. Thiel W, Borho B. Posttraumatische Kniegelenksergüsse und intraartikuläre Traumeel-N-Injektion. Orthopädische Prax. 1991; 27(11): 721–5.
  10. 10. Böhmer D, Ambrus P. Treatment of sports injuries with Traumeel ointment: a controlled double-blind study. Biol Ther. 1992;10(4):290–300.
  11. Arora S, Harris T, Scherer C. Clinical safety of a homeopathic preparation. Biomed Ther. 2000;18(2):222–5.
  12. González de Vega C, Speed C, Wolfarth B, González J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: A multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract. 2013;67(10):979-989. doi:10.1111/ijcp.12219.
  13. Lozada C, del Rio E, Reitberg DP, Smith R, Moskowitz RW. Risk-benefit of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections in patients with moderate-to-severe pain associated with OA of the knee (OAK) (THU0441). Ann Rheum Dis. 2015;74(suppl 2):4268. doi: 10.1136/annrheumdis-2015-eular.426810.
  14. Lozada C, del Rio E, Reitberg D, Smith R, Kahn C, Moskowitz RW. A multi-center double-blind, randomized, controlled trial (db-RCT) to evaluate the effectiveness and safety of co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections versus IA placebo in patients with moderate-to-severe pain associated with OA of the knee. Arthritis Rheum. 2014;66(suppl):S1266.
  15. Zenner S, Metelmann H. Therapy experiences with a homeopathic ointment: Results of drug surveillance conducted on 3,422 patients. Biol Ther. 1994;12(3):204–211.
  16. Zenner S, Metelmann H. Application possibilities of Traumeel S injection solution: Results of a multicentric drug monitoring trial conducted on 3,241 patients. Biol Ther. 1992;10(4):301–10.
  17. Zenner S, Weiser M. Oral treatment of traumatic, inflammatory, and degenerative conditions with a homeopathic remedy. Biomed Ther. 1997;15(1):22–6.
  18. Weiser M, Zenner S. Orale Therapie traumatischer, entzündlicher und degenerativer Affektionen mit einem Homöopathikum. Biol Medizin. 1996;25(5):211–6.
  19. Ludwig J, Weiser M. Treating pediatric trauma with a homeopathic ointment. J Biomed Ther. 2001;(2):8–11.
  20. Birnesser H, Oberbaum M, Klein P, Weiser M. The homeopathic preparation Traumeel S compared with NSAIDs for symptomatic treatment of epicondylitis. J Musculoskelet Res. 2004;8(2 & 3):119-128. doi:10.1142/S0218957704001284.
  21. Schneider C, Schneider B, Hanisch J, van Haselen R. The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med. 2008;16(1):22–7. doi:10.1016/j.ctim.2007.04.004.
  22. Schneider C, Klein P, Stolt P, Oberbaum M. A homeopathic ointment preparation compared with 1% diclofenac gel for acute symptomatic treatment of tendinopathy. Explore (NY). 2005;1(6):446–52. doi:10.1016/j.explore.2005.08.010.
  23. Conforti A, Bertani S, Lussignoli S, Bellavite P. Wirkungen Antihomotoxischer Präparate auf akute und chronische Entzündungen. Biol Medizin. 1998;27(2):63–6.
  24. Conforti A, Bertani S, Metelmann H, Chirumbolo S, Lussignoli S, Bellavite P. Experimental studies on the anti-inflammatory activity of a homeopathic preparation. Biomed Ther. 1997;15(1):28–31.
  25. Enbergs H. The effect of selected potentiated suis organ preparations and Traumeel on phagocyte and lymphocyte activity. Biomed Ther. 1998;16(2):178–85.
  26. Lussignoli S, Bertani S, Metelmann H, Bellavite P, Conforti A. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med. 1999;7(4):225–30.
  27. Heine H, Andrä F. On the anti-inflammatory mechanism of action of an antihomotoxic compound remedy [in German]. Ärztezeitschrift für Naturheilverfahren. 2002;43(2):96–104.
  28. Porozov S, Cahalon L, Weiser M, Branski D, Lider O, Oberbaum M. Inhibition of IL-1β and TNF-α secretion from resting and activated human immunocytes by the homeopathic medication Traumeel® S. Clin Dev Immunol. 2004;11(2):143–9. doi:10.1080/10446670410001722203.
  29. Seilheimer B, Wierzchacz C, Gebhardt R. Influence of Traumeel on cultured chondrocytes and recombinant human matrix metalloproteinases: implications for chronic joint diseases. Eur J Integr Med. 2009;1(4):252–3.
  30. St. Laurent G, Tackett M, McCaffrey T, Kapranov P. Deep sequencing transcriptome analysis of Traumeel therapeutic action in wound healing (THU0016). Ann Rheum Dis. 2013;72(suppl 3). doi:10.1136/annrheumdis-2013-eular.544.
  31. Wolfarth B, González de Vega C, Kapranov P, St Laurent G, Speed C. Inflammation in soft tissue disorders: the evidence and potential role for a natural multi-target medication. Curr Med Res Opin. 2013;29(suppl 2):1–2. doi:10.1185/03007995.2013.779874.
  32. Speed C, González de Vega C. Treatment of musculo-skeletal inflammatory disorders using a clinically proven medication with a novel mechanism of action. Ann Rheum Dis. 2011;70(suppl 3):685.
  33. Cesnulevicius K. The bioregulatory approach to work-related muskuloskeletal disorders: using the multicomponent ultra low-dose medication Traumeel to target the multiple pathophysiological processes of the disease. Altern Ther Health Med. 2011;17(suppl 2):S8–17.
  34. Orchard JW, Best TM, Mueller-Wohlfahrt HW, et al. The early management of muscle strains in the elite athlete: best practice in a world with a limited evidence basis. Br J Sports Med. 2008;42(3):158–9. doi:10.1136/bjsm.2008.046722.
  35. González de Vega C, Gonzáles J. A randomized, controlled, multicenter study on the effectiveness of Traumeel (ointment and gel) in terms of pain reduction and function improvement compared with diclofenac gel in acute ankle sprain. Ann Rheum Dis. 2012;71(suppl 3):SAT0423.